Integrating signals from the T-cell receptor and the interleukin-2 receptor

PLoS Computational Biology

Volumn 7, Issue 8, 2011, Pages

  Beyer, Tilo ^a   Busse, Mandy ^a,c   Hristov, Kroum ^a   Gurbiel, Slavyana ^a   Smida, Michal ^a,d   Haus, Utz Uwe ^a,e   Ballerstein, Kathrin ^a,e   Pfeuffer, Frank ^a   Weismantel, Robert ^a,e   Schraven, Burkhart ^a,b   Lindquist, Jonathan A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CELL SIGNALING; CYTOLOGY; DISEASE CONTROL; ENZYMES; MERGERS AND ACQUISITIONS; SIGNALING; T-CELLS;

'CURRENT; ADAPTIVE IMMUNE RESPONSE; DISEASE PROGRESSION; DRUG TARGETS; IMMUNOSUPPRESSIVE THERAPY; INTERLEUKIN2 (IL2); LOGICAL MODELS; OPPORTUNISTIC INFECTIONS; RECEPTOR SIGNALING; T CELLS RECEPTORS;

CHEMICAL ACTIVATION;

INTERLEUKIN 2 RECEPTOR; JANUS KINASE; LAT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE C;

ARTICLE; CELL COMMUNICATION; CELL FATE; CELL SPECIFICITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR MODEL; PREDICTION; PROCESS DEVELOPMENT; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SIMULATION; BIOLOGICAL MODEL; CELL CULTURE; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; REPRODUCIBILITY; T LYMPHOCYTE;

CELLS, CULTURED; HUMANS; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTES;

EID: 80052335716     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002121     Document Type: Article

References (58)

1. Pentcheva-Hoang T, Corse E, Allison JP, (2009) Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol Rev 229: 67-87.
2. Lindquist JA, Schraven B, (2007) Systems biology of T cell activation. Ernst Schering Found Symp Proc pp. 43-61.
3. Saez-Rodriguez J, Simeoni L, Lindquist JA, Hemenway R, Bommhardt U, et al. (2007) A logical model provides insights into T cell receptor signaling. PLoS Comput Biol 3: e163.
4. Henderson DJ, Naya I, Bundick RV, Smith GM, Schmidt JA, (1991) Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production. Immunol 73: 316-321.
5. Nelson BH, Willerford DM, (1998) Biology of the interleukin-2 receptor. Adv Immunol 70: 1-81.
6. Haus U-U, Niermann K, Truemper K, Weismantel R, (2009) Logic Integer Programming Models for Signaling Networks. J Comp Biol 16: 725-743.
7. Büning HK, Lettmann T, (1999) Propositional Logic: Deduction and Algorithms Cambridge University Press.
8. Busse D, de la Rosa M, Hobiger K, Thurley K, Flossdorf M, et al. (2010) Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc Natl Acad Sc USA 107: 3058-3063.
9. Feinerman O, Jentsch G, Tkach KE, Coward JW, Hathorn MM, et al. (2010) Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Syst Biol 6: 437.
10. Burroughs NJ, Miguel Paz Mendes de Oliveira B, Adrego Pinto A, (2006) Regulatory T cell adjustment of quorum growth thresholds and the control of local immune responses. J Theor Biol 241: 134-141.
11. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, et al. (2009) PID: The Pathway Interaction Database. Nucleic Acids Res 37: D674-9.
12. Taichman R, Merida I, Torigoe T, Gaulton GN, Reed JC, (1993) Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3′-kinase in interleukin-2-dependent T-cells. J Biol Chem 268: 20031-20036.
13. Zhou YJ, Magnuson KS, Cheng TP, Gadina M, Frucht DM, et al. (2000) Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of Syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation. Mol Cell Biol 20: 4371-4380.
14. Minami Y, Kono T, Yamada K, Kobayashi N, Kawahara A, et al. (1993) Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck. EMBO J 12: 759-768.
15. Karnitz LM, Burns LA, Sutor SL, Blenis J, Abraham RT, (1995) Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol Cell Biol 15: 3049-3057.
16. Clark RB, Love JT, Sgroi D, Lingenheld EG, Sha'afi RI, (1987) The protein kinase C inhibitor H-7, inhibits antigen and IL-2-induced proliferation of murine T cell lines. Biochem Biophys Res Commun 145: 666-672.
17. Fong TC, Makinodan T, (1989) Preferential enhancement by 2-mercaptoethanol of IL-2 responsiveness of T blast cells from old over young mice is associated with potentiated protein kinase C translocation. Immunol Lett 20: 149-154.
18. Gómez J, Pitton C, García A, Martinez de Aragón A, Silva A, et al. (1995) The zeta isoform of protein kinase C controls interleukin-2-mediated proliferation in a murine T cell line: evidence for an additional role of protein kinase C epsilon and beta. Exp Cell Res 218: 105-113.
19. Gómez J, García A, R-Borlado L, Bonay P, Martínez-A C, et al. (1997) IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. J Immunol 158: 1516-1522.
20. Mahé Y, Piau JP, Wakasugi N, Tursz T, Gacon G, et al. (1988) Comparison of interleukin 2 and 12-O-tetradecanoylphorbol 13-acetate as signals for protein kinase C activation in purified human T lymphocytes. Eur J Immunol 18: 2029-2036.
21. Redondo JM, López-Rivas A, Vila V, Cragoe EJ, Fresno M, (1988) The role of protein kinase C in T lymphocyte proliferation. Existence of protein kinase C-dependent and-independent pathways. J Biol Chem 263: 17467-17470.
22. Valge VE, Wong JG, Datlof BM, Sinskey AJ, Rao A, (1988) Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell 55: 101-112.
23. Sawami H, Terada N, Franklin RA, Okawa H, Uchiyama T, et al. (1992) Signal transduction by interleukin 2 in human T cells: activation of tyrosine and ribosomal S6 kinases and cell-cycle regulatory genes. J Cell Physiol 151: 367-377.
24. Farrar WL, Anderson WB, (1985) Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature 315: 233-235.
25. Lu Y, Morley P, Durkin JP, (1999) Signalling events mediating the activation of protein kinase C by interleukin-2 in cytotoxic T cells. Cell Signal 11: 275-285.
26. Grandage VL, Everington T, Linch DC, Khwaja A, (2006) Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. Br J Haematol 135: 303-316.
27. Puente LG, He J-S, Ostergaard HL, (2006) A novel PKC regulates ERK activation and degranulation of cytotoxic T lymphocytes: Plasticity in PKC regulation of ERK. Eur J Immunol 36: 1009-1018.
28. Puente LG, Stone JC, Ostergaard HL, (2000) Evidence for protein kinase C-dependent and-independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins. J Immunol 165: 6865-6871.
29. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, et al. (1994) The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303: 21-26.
30. Knall C, Young S, Nick JA, Buhl AM, Worthen GS, et al. (1996) Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem 271: 2832-2838.
31. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, et al. (2003) Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 278: 13061-13068.
32. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, et al. (1993) Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364: 249-252.
33. Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjölander A, (2002) Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 115: 1883-1893.
34. Hugues S, Fetler L, Bonifaz L, Helft J, Amblard F, et al. (2004) Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 5: 1235-1242.
35. Zimmermann C, Prévost-Blondel A, Blaser C, Pircher H, (1999) Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur J Immunol 29: 284-290.
36. Sojka DK, Bruniquel D, Schwartz RH, Singh NJ, (2004) IL-2 secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition. J Immunol 172: 6136-6143.
37. Yaqub S, Abrahamsen H, Zimmerman B, Kholod N, Torgersen KM, et al. (2003) Activation of C-terminal Src kinase (Csk) by phosphorylation at serine-364 depends on the Csk-Src homology 3 domain. Biochem J 372: 271-278.
38. Börner C, Kraus J, Bedini A, Schraven B, Höllt V, (2008) T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors. Mol Pharmacol 74: 496-504.
39. Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, et al. (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 193: 497-507.
40. Hodgkin MN, Pettitt TR, Martin A, Michell RH, Pemberton AJ, et al. (1998) Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem Sci 23: 200-204.
41. Villalba M, Bi K, Hu J, Altman Y, Bushway P, et al. (2002) Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol 157: 253-263.
42. Priatel JJ, Chen X, Huang Y-H, Chow MT, Zenewicz LA, et al. (2010) RasGRP1 regulates antigen-induced developmental programming by naive CD8 T cells. J Immunol 184: 666-676.
43. Tauzin S, Ding H, Khatib K, Ahmad I, Burdevet D, et al. (2008) Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Blood 111: 2310-2320.
44. Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, et al. (1994) Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 13: 5605-5615.
45. Welte T, Leitenberg D, Dittel BN, al-Ramadi BK, Xie B, et al. (1999) STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283: 222-225.
46. Gerwien J, Nielsen M, Labuda T, Nissen MH, Svejgaard A, et al. (1999) Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells. J Immunol 163: 1742-1745.
47. Aman MJ, Migone TS, Sasaki A, Ascherman DP, Zhu M, et al. (1999) CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling. J Biol Chem 274: 30266-30272.
48. Alvarez JV, Frank DA, (2004) Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol Ther 3: 1045-1050.
49. Sauer K, Liou J, Singh SB, Yablonski D, Weiss A, et al. (2001) Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes. J Biol Chem 276: 45207-45216.
50. Liou J, Kiefer F, Dang A, Hashimoto A, Cobb MH, et al. (2000) HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity 12: 399-408.
51. Cho J-H, Kim H-O, Surh CD, Sprent J, (2010) T cell receptor-dependent regulation of lipid rafts controls naive CD8+ T cell homeostasis. Immunity 32: 214-226.
52. Lindquist JA, Simeoni L, Schraven B, (2003) Transmembrane adapters: attractants for cytoplasmic effectors. Immunol Rev 191: 165-182.
53. Wang X, Simeoni L, Lindquist JA, Saez-Rodriguez J, Ambach A, et al. (2008) Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature CD8+ T cells. J Immunol 180: 6703-6712.
54. Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, et al. (2006) Reversal of the TCR stop signal by CTLA-4. Science 313: 1972-1975.
55. Naldi A, Carneiro J, Chaouiya C, Thieffry D, (2010) Diversity and plasticity of Th cell types predicted from regulatory network modelling. PLoS Comput Biol 6: e1000912.
56. Wittmann DM, Krumsiek J, Saez-Rodriguez J, Lauffenburger DA, Klamt S, et al. (2009) Transforming Boolean models to continuous models: methodology and application to T-cell receptor signaling. BMC Syst Biol 3: 98.
57. Deenick EK, Gett AV, Hodgkin PD, (2003) Stochastic model of T cell proliferation: a calculus revealing IL-2 regulation of precursor frequencies, cell cycle time, and survival. J Immunol 170: 4963-4972.
58. Arazi A, Sharabi A, Zinger H, Mozes E, Neumann AU, (2009) In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice. PLoS ONE 4: e8447.